Update on Treatment and Prevention of Chronic Antibody Mediated Rejection in Renal Transplant Recipients | Zendy

Salman Tahir Shafi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Update on Treatment and Prevention of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

Author(s) -

Salman Tahir Shafi

Publication year - 2021

Publication title -

pakistan journal of kidney diseases

Language(s) - English

Resource type - Journals

eISSN - 2708-3020

pISSN - 2617-0329

DOI - 10.53778/pjkd40353

Subject(s) - medicine , immunology , antibody , complement dependent cytotoxicity , cytotoxicity , proteinuria , renal transplant , chronic renal failure , complement system , complement (music) , chronic renal disease , transplantation , kidney disease , antibody dependent cell mediated cytotoxicity , kidney , biology , monoclonal antibody , in vitro , biochemistry , phenotype , complementation , gene

Chronic antibody mediated rejection (AMR) is a major cause of allograft failure1,2. Chronic AMR clinically presents with proteinuria and gradual decline in renal function. The underlying mechanisms of AMR include both antibody mediated complement-dependent cytotoxicity, complement-independent cellular cytotoxicity and other mechanisms. The purpose of this review is to appraise recent literature on diagnosis, treatment and prevention of chronic AMR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research